Michael Alfieri serves as the Principal Financial Officer and Principal Accounting Officer at Aldeyra Therapeutics Inc., a biotechnology company focused on developing and commercializing novel therapies for immune-mediated diseases. In his role, Alfieri is responsible for overseeing the company's financial operations, ensuring accurate financial reporting, and maintaining compliance with regulatory requirements. His leadership has been instrumental in guiding Aldeyra through its growth phases and navigating the complexities of the biotechnology industry. Before joining Aldeyra Therapeutics, Alfieri amassed a wealth of experience in financial management within the life sciences sector. He held various senior financial positions at other biotechnology firms, where he honed his skills in financial strategy, corporate governance, and investor relations. Alfieri's strategic financial planning and deep understanding of the biotech market have been pivotal in supporting Aldeyra's mission to bring innovative treatments to patients suffering from immune-mediated diseases. His contributions have helped position the company for long-term success and sustainability. Alfieri's achievements at Aldeyra include successfully managing the company's financial resources to support its research and development initiatives, as well as facilitating key partnerships and collaborations that have advanced the company's pipeline. His dedication to maintaining transparency and integrity in financial reporting has earned him respect among stakeholders and has been crucial in building investor confidence. As Aldeyra continues to progress towards its goals, Alfieri's role remains vital in steering the company's financial strategy and ensuring its continued growth and innovation in the biotechnology field.